| Period Ending | Mar 30, 2013 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
|---|
|
Total Revenue
|
235,944
|
160,756
|
224,422
|
105,434
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
235,944
|
160,756
|
224,422
|
105,434
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 194,543 | 80,952 | 92,608 | 89,918 |
|
Non Recurring | 370 | 730 | 3,180 | 3,486 |
|
Others | 32,130 | 28,366 | 39,897 | 13,588 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
10,997
|
7,452
|
(13)
|
3,497
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 35,527 | 3,123 | 788 | 4,763 |
|
Earnings Before Interest And Taxes | 100,666 | 54,561 | 45,298 | 54,098 |
|
Interest Expense | 54,142 | 43,986 | 44,523 | 45,838 |
|
Income Before Tax | 46,524 | 10,575 | 775 | 8,260 |
|
Income Tax Expense | 18,775 | 4,164 | 347 | 3,125 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 27,749 | 6,411 | 428 | 5,135 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
27,749
|
6,411
|
428
|
5,135
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
27,749
|
6,411
|
428
|
5,135
|
|
1.06(2.78%) 2:08PM EDT - Nasdaq Real Time Price